Avacta Group plc appoints Zeus Capital as Joint Broker

Avacta Group plc (AIM: AVCT), the developer of Affimer ^®biotherapeutics and research reagents , is pleased to announce the appointment of Zeus Capital Limited as joint broker with immediate effect.